Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.21.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
REVENUES
OPERATING EXPENSES FROM CONTINUED OPERATIONS    
Payroll and related expenses 372,938 650,160
Professional fees 442,795 437,282
General and administrative 146,207 42,251
Research and development expenses 362,456
Total Operating Expenses 1,324,396 1,129,693
LOSS FROM CONTINUING OPERATIONS (1,324,396) (1,129,693)
OTHER INCOME (EXPENSE) FROM CONTINUING OPERATIONS    
Financing costs including interest (490,402) (540,877)
Change in fair value of convertible bridge notes (3,170,236) 1,057,877
Loss on equity method investment (21,588)
Loss on convertible debt and other liabilities converted to equity (834,903)
Total Other (Expense) Income (4,495,541) 495,412
Loss from continuing operations before income taxes (5,819,937) (634,281)
INCOME TAXES
Loss from continuing operations (5,819,937) (634,281)
DISCONTINUED OPERATIONS:    
Income (Loss) from discontinued operations before income taxes 957,254 (47,698)
INCOME TAXES
Income (Loss) from discontinued operations 957,254 (47,698)
NET LOSS (4,862,683) (681,979)
PREFERRED STOCK    
Series A convertible contractual dividends (35,440) (36,000)
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (4,898,123) $ (717,979)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS: BASIC AND DILUTED:    
CONTINUING OPERATIONS $ (1.06) $ (0.32)
DISCONTINUED OPERATIONS 0.17 (0.02)
Earnings Per Share, Basic and Diluted $ (0.88) $ (0.34)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: BASIC AND DILUTED 5,522,771 2,079,898